Overview

Combination Chemotherapy in Treating Patients With Advanced or Metastatic Colorectal Cancer

Status:
Completed
Trial end date:
2003-12-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Randomized phase II trial to study the effectiveness of combination chemotherapy in treating patients who have advanced or metastatic colorectal cancer.
Phase:
Phase 2
Details
Lead Sponsor:
Swiss Group for Clinical Cancer Research
Treatments:
Camptothecin
Capecitabine
Irinotecan